SIRTURO
Active substance: bedaquiline
TABLET · BEDAQUILINE FUMARATE 100 mg/1
United StatesActive
Marketing holder: Janssen Products, LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- BEDAQUILINE FUMARATE · 100 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-977b-72f8-8b13-f8e6c32a96d3,01a120c3-9dc5-7f83-b82d-33debdf93eaa,01a120c3-c7f9-72dc-ace7-d489b77da51d,01a120c3-d138-7d95-b35f-2421be19ad7e,01a120c3-f6ce-7a21-b5f8-5ecc9de7ff00;count=6 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-8b9f-70b6-a989-05dd6f983eb5,01a12098-e07f-7881-be56-f8a398beccb6;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59676-701
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59676-701 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59676-701 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59676-701 · Verified 2026-10-09 · open in source